As of 2026-11-06, the Relative Valuation of PolyPeptide Group AG (PPGN.SW) is 17.14 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 40.50 CHF, the upside of PolyPeptide Group AG based on Relative Valuation is -57.7%.
The range of the Relative Valuation is 15.19 - 22.12 CHF.
| Range | Selected | |
| Trailing P/E multiples | 36.0x - 50.7x | 40.2x |
| Forward P/E multiples | 34.8x - 49.3x | 38.4x |
| Fair Price | 15.19 - 22.12 | 17.14 |
| Upside | -62.5% - -45.4% | -57.7% |
| Date | P/E |
| 2026-11-05 | 92.85 |
| 2026-11-04 | 94.80 |
| 2026-11-03 | 97.66 |
| 2026-11-02 | 94.80 |
| 2026-10-30 | 96.29 |
| 2026-10-29 | 99.50 |
| 2026-10-28 | 100.19 |
| 2026-10-27 | 100.41 |
| 2026-10-26 | 100.41 |
| 2026-10-23 | 100.76 |
| 2026-10-22 | 101.22 |
| 2026-10-21 | 101.10 |
| 2026-10-20 | 100.99 |
| 2026-10-19 | 100.99 |
| 2026-10-16 | 100.76 |
| 2026-10-15 | 100.87 |
| 2026-10-14 | 101.10 |
| 2026-10-13 | 101.56 |
| 2026-10-12 | 100.76 |
| 2026-10-09 | 100.53 |
| 2026-10-08 | 100.64 |
| 2026-10-07 | 100.64 |
| 2026-10-06 | 100.99 |
| 2026-10-05 | 100.99 |
| 2026-10-02 | 101.10 |
| 2026-10-01 | 101.10 |
| 2026-09-30 | 101.10 |
| 2026-09-29 | 100.99 |
| 2026-09-28 | 101.10 |
| 2026-09-25 | 101.10 |
| 2026-09-24 | 101.22 |
| 2026-09-23 | 101.33 |
| 2026-09-22 | 101.10 |
| 2026-09-21 | 100.87 |
| 2026-09-18 | 100.87 |
| 2026-09-17 | 100.99 |
| 2026-09-16 | 101.10 |
| 2026-09-15 | 100.99 |
| 2026-09-14 | 100.87 |
| 2026-09-11 | 100.99 |
| 2026-09-10 | 100.87 |
| 2026-09-09 | 100.87 |
| 2026-09-08 | 100.87 |
| 2026-09-07 | 100.87 |
| 2026-09-04 | 100.76 |
| 2026-09-03 | 100.76 |
| 2026-09-02 | 100.99 |
| 2026-09-01 | 100.87 |
| 2026-08-31 | 100.99 |
| 2026-08-28 | 100.87 |